Mylan Pharmaceuticals glipiZIDE Extended-Release Tablets Recall

Why it was recalled

Presence of Foreign Tablets/Capsules; bottles of Glipizide 5 mg tablets may contain Glipizide 10 mg tablets

Product description

glipiZIDE Extended-Release Tablets, 5 mg, 1000 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-0342-10

Lot numbers, UPCs & expiration codes

Batch # 3074621, June 2018

Where it was sold

Nationwide

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0491-2017
Classification: Class II
Status: Terminated
Recall initiated: Jan 19, 2017
FDA report date: Mar 8, 2017
Quantity: 1338 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Mylan Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0491-2017, exactly as published.

Show all FDA fields

City: Morgantown
State: WV
Status: Terminated
Country: United States
Event ID: 76291
Address: 781 Chestnut Ridge Rd
Code information: Batch # 3074621, June 2018
Postal code: 26505-2730
Report date: Mar 8, 2017
Product type: Drugs
Recall number: D-0491-2017
Classification: Class II
Recalling firm: Mylan Pharmaceuticals Inc.
Product quantity: 1338 bottles
Termination date: Jul 20, 2017
Reason for recall: Presence of Foreign Tablets/Capsules; bottles of Glipizide 5 mg tablets may contain Glipizide 10 mg tablets
Voluntary / mandated: Voluntary: Firm initiated
Product description: glipiZIDE Extended-Release Tablets, 5 mg, 1000 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-0342-10
Distribution pattern: Nationwide
Recall initiation date: Jan 19, 2017
Initial firm notification: E-Mail
Center classification date: Feb 24, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0491-2017, published Mar 8, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.